Procalcitonin in acute myocardial infarction

References

• Le Moullec J. M., Jullienne A., Chenais J., Lasmoles F., Guliana J. M., Milhaud G., et al. The complete sequence of human preprocalcitonin. FEBS Lett 1984; 167: 93–7
   PubMed Web of Science ®Google Scholar
• Adema G. J., Bass P. D. A novel calcitonin‐encoding mRNA is produced by alternative processing of calcitonin/calcitonin gene‐related peptide‐I pre‐mRNA. J Biol Chem 1992; 267: 7943–8
   PubMedGoogle Scholar
• AI‐Nawas B., Shah P. M. Procalcitonin in patients with and without immunosupression and sepsis. Infection 1996; 24: 434–6
   Google Scholar
• Giamarellos‐Bourboulis E. J., Giannopoulou P., Greka P., Voros D., Mandragos K., Giamarellou H. Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis?. J Crit Care 2004; 19: 152–7
   Google Scholar
• Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515–8
   PubMed Web of Science ®Google Scholar
• Snider R. H., Jr., Nylen E. S., Becker K. L. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med 1997; 45: 552–60
   PubMed Web of Science ®Google Scholar
• Dandona P., Nix D., Wilson M. F., Aljada A., Love J., Assicot M., et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79: 1605–8
   PubMed Web of Science ®Google Scholar
• Geppert A., Steiner A., Delle‐Karth G., Heinz G., Huber K. Usefulness of procalcitonin for diagnostic complicating sepsis in patients with cardiogenic shock. Intensive Care Med 2003; 29: 1384–9
   PubMed Web of Science ®Google Scholar
• Meisner M. Procalcitonin (PCT). A new, innovative infection parameter. Biochemical and clinical aspects. Stuttgart, Georg Thieme. Verlag, New York 2000; 200, 9
   Google Scholar
• Meisner M., Hutzler A., Tschaikowsky K., Harig F., von der Emde J. Postoperative plasma concentrations of procalcitonin and C‐reactive protein in patients under‐going cardiac and thoracic surgery with and without cardiopulmonary bypass. Cardiovasc Engineering 1998; 3: 174–8
   Google Scholar
• Meisner M., Tschaikowsky K., Hutzler A., Schick C., Schuttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998; 24: 680–4
   PubMed Web of Science ®Google Scholar
• Mimoz O., Benoist J. F., Edouard A. R., Assicot M., Bohuon C., Samii K. Procalcitonin and C‐reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998; 24: 185–8
   PubMed Web of Science ®Google Scholar
• Brunkhorst F. M., Forycki Z. F., Wagner J. Procalcitonin immunoreactivity in severe human shock. Intens Care Med 1995; 6: 3
   Google Scholar
• Buratti T., Ricevuti G., Pechlaner C., Ioannidis M., Wiedermann F., Gritti D., et al. Plasma levels of procalcitonin and interleukin‐6 in acute myocardial infarction. Inflammation 2001; 25: 97–100
   PubMed Web of Science ®Google Scholar
• Remskar M., Horvat M., Hojker S., Noc M. Procalcitonin in patiens with acute myocardial infarction. Wien Klin Wochenschr 2002; 114: 205–10
   PubMed Web of Science ®Google Scholar
• Becker K. L., Gazdar A. F. What can the biology of too small cell cancer of the lung teach us about the endocrine lung?. Biochem Pharmacol 1985; 34: 155–9
   PubMed Web of Science ®Google Scholar
• Brunkhorst F. M., Heinz U., Forycki Z. F. Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 1998; 24: 888–9
   PubMed Web of Science ®Google Scholar
• Hirsch A., Windhausen F., Tijssen J., Verheugt F., Cornel J., Winter R., for the Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) investigators. Long‐term outcome after an early invasive versus selective invasive treatment strategy in patients with non‐ST‐elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow up study. Lancet 2007; 369: 827–35
   PubMedGoogle Scholar
• Wagner F. D., Jonitz B., Potapov E. V., Qedra N., Wegscheider K., Abraham K., et al. Procalcitonin, a donor‐specific predictor of early graft failure‐related mortality after heart transplantation. Circulation 2001; 104((Suppl 1))I192–6
   PubMed Web of Science ®Google Scholar
• Dandona P., Nix D., Wilson M. F., Aljada A., Love J., Assicot M., et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79: 1605–8
   PubMed Web of Science ®Google Scholar
• Oberhoffer M., Bogel D., Meier‐Hellman A., Vogelsang H., Reinhart K. Procalcitonin is higher in non‐survivors during the clinical course of sepsis, severe sepsis and septic shock. Intensive care Med 1996; 22: A245
   Google Scholar
• Davis T. M., Assicot M., Bohuon C., St John A., Li G. Q., Anh T. K. Serum procalcitonin concentrations in acute malaria. Trans R Soc Trop Med Hyg 1994; 88: 670–1
   PubMed Web of Science ®Google Scholar
• Nylen E. S., Al Arifi A., Becker K. L., Snider R. H., Jr., Alzeer A. Effect of classic heatstroke on serum procalcitonin. Crit Care Med 1997; 25: 1362–5
   PubMed Web of Science ®Google Scholar
• Hergert M., Lestin H. G., Scherkus M., Brinker K., Klett I., Stranz G., et al. Procalcitonin in patients with sepsis and polytrauma. Clin Lab 1998; 44: 659–70
   Google Scholar
• Carsin H., Assicot M., Feger F., Roy O., Pennacino I., Le Bever H., et al. Evolution and significance of circulating procalcitonin levels compared with IL‐6, TNF alpha and endotoxin levels early after thermal injury. Burns 1997; 23: 218–24
   PubMed Web of Science ®Google Scholar
• Sturk A., Hack C. E., Aarden L. A., Brouwer M., Koster R. R., Sanders G. T. Interleukin‐6 release and the acute‐phase reaction in patients with acute myocardial infarction: a pilot study. J Lab Clin Med 1992; 119: 574–9
   Google Scholar
• Oberhoffer M., Karzai W., Meier‐Hellmann A., Bogel D., Fassbinder J., Reinhart K. Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor‐alpha and interleukin‐6 in patients with sepsis. Crit Care Med 1999; 27: 1814–8
   Google Scholar
• Meisner M. Procalcitonin: Erfahrungen mit einer neuen Messgroesse fuer bakterielle Infektionen und systemische Inflammation. J Lab Med 1999; 23: 263–72
   Google Scholar
• Waydhas C., Nast‐Kolb D., Jochum M., Trupka A., Lenk S., Fritz H., et al. Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma. Arch Surg 1992; 127: 460–7
   PubMedGoogle Scholar
• Lietzman A. Untersuchungen zum Syntheseort und zur Induktion des neuen infektionsparameters Procalcitonin. 1999, Dissertation, FAU‐Erlangen‐Nürnberg
   Google Scholar
• Liuzzo G., Biasucci L., Gallimore J., Caligiuri G., Buffon A., Rebuzzi A., et al. Enhanced Inflammatory Response in Patients With Preinfarction Unstable Angina. J Am Coll Cardiol 1999; 34: 1696–703
   PubMed Web of Science ®Google Scholar
• Liuzzo G., Biasucci L., Gallimore J., Grillo R., Rebuzzi A., Pepys M., et al. The prognostic value of C‐reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417–24
   PubMed Web of Science ®Google Scholar
• Wu T. L., Chen Tsai I., Chang P. Y., Tsao K. C., Sun C. F., Wu L. L., et al. Establishment of an in‐house ELISA and the reference range for serum amyloid A (SAA): complementarity between SAA and C‐reactive protein as markers of inflammation. Clin Chim Acta 2007; 376: 72–6
   PubMed Web of Science ®Google Scholar
• Dahi T. B., Yndestad A., Skielland M., Oie E., Dahi A., Michelsen A., et al. Increased expession of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation, 115: 972–80
   Google Scholar
• Steiwald P. M., Becker K. L., Nylen E. S., Snider R. H., White J. C. Hyperprocalcitonemia of E.coli sepsis in a hamster model: association with hypocalcemia and hyperphosphatemia. Abstract on the 10th Internat Congress of Endocrinology. 1998, June 1996, San Francisco, CA
   Google Scholar
• Meisner M., Rauschmayer C., Schmidt J. Procalcitonin indicates increased risk after cardiovascular surgery. Shock 1999; 12((Suppl))16–7
   Google Scholar